AzTrials
AzTrials

LipedemaLIP-MOVENCT07917195

Mind-Body Chair Yoga for Functional Mobility in Individuals With Lipedema

A study testing Mind-Body Chair Yoga + Support Group and Support Group in people with Lipedema, run by Cynthia Beers.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Lipedema is a chronic condition characterized by abnormal accumulation and distribution of adipose tissue, most commonly affecting the lower extremities, and may be associated with swelling, discomfort, reduced mobility, and changes in physical and emotional well-being. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Lipedema
What is being tested?
Mind-Body Chair Yoga + Support Group and Support Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
73 participants
Where
No sites listed yet
Study dates
Jan 2027to Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants must meet all of the following criteria:
  • Be designated female at birth.
  • Be at least 18 years of age.
  • Have a formal diagnosis of lipedema.
  • Meet the eligibility screening requirements based on the framework for research case definitions of lipedema proposed by Keith et al. (2024).
  • Be able to read, speak, and understand English.
  • Have access to the internet to participate in the remotely delivered study activities.

Who cannot join

  • Individuals will be excluded from enrollment if they meet any of the following criteria:
  • Have a cardiovascular condition or have undergone surgery within the previous 6 weeks for which exercise is contraindicated without physician clearance.
  • Have an active infection.
  • Have an untreated deep vein thrombosis (DVT).
  • Have a high-risk pregnancy.
  • Have cognitive or psychiatric disabilities that prevent the individual from providing informed consent.
  • Have a diagnosed serious mental health condition.
  • Have experienced a recent major life crisis.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Cynthia L Beers, Principal Investigator, MS 500ERYT contact

717-571-4610

cindy@cindybeers.com

Leslyn Keith, OTD contact

805-748-6519

leslynkeithot@gmail.com

About this study

Official title: The Feasibility and Effectiveness of a Remote Mind-Body Chair Yoga Intervention on Functional Mobility in Individuals With Lipedema: A Randomized Controlled Trial

Lipedema is a chronic condition characterized by abnormal accumulation and distribution of adipose tissue, most commonly affecting the lower extremities, and may be associated with swelling, discomfort, reduced mobility, and changes in physical and emotional well-being. Although exercise and movement are commonly recommended as part of supportive care, there is limited clinical research examining whether a structured, remotely delivered mind-body chair yoga program can improve functional mobility in individuals with lipedema.

This study will evaluate the feasibility and effectiveness of a remote mind-body chair yoga intervention on functional mobility in adults with lipedema. The study builds on a previous citizen-science quality-of-life yoga program and is designed to further evaluate the intervention using a prospective clinical research design.

Read more

Participants will be randomly assigned in a 1:1 ratio to one of two groups. The intervention group will participate in a structured mind-body chair yoga program in addition to a weekly support group. The comparison group will participate in the weekly support group without yoga during the primary study period. After completion of the study, participants in the comparison group will be offered access to the chair yoga program.

The mind-body chair yoga intervention will be delivered remotely and will incorporate gentle chair-based yoga, breathing practices, relaxation, meditation, and other accessible mind-body practices. The program is designed to accommodate individuals with varying levels of mobility and physical ability and does not require participants to perform yoga poses on the floor.

The primary outcome of the study is functional mobility. Secondary outcomes will examine changes in lipedema symptom severity, pain, sleep, and mental well-being. Participant experiences and perceptions of the intervention will also be explored using qualitative measures.

The study will assess whether a remotely delivered mind-body chair yoga program is feasible for individuals with lipedema and whether participation is associated with improvements in functional mobility and other quality-of-life-related outcomes. Findings may help inform future research and the development of accessible mind-body movement programs for individuals living with lipedema.

Read the detailed description

Lipedema is a chronic, often progressive adipose tissue disorder characterized by disproportionate and symmetrical accumulation of adipose tissue, most commonly affecting the lower extremities. The condition may be associated with swelling, tenderness or pain, heaviness, impaired physical function, and changes in body image and quality of life. Functional limitations may increase over time and can affect participation in daily activities and exercise.

Movement and exercise are commonly included among conservative approaches to managing lipedema. However, individuals with lipedema may experience physical limitations, discomfort, fatigue, reduced confidence with movement, or difficulty accessing exercise programs designed for their needs. Accessible movement approaches that can be adapted to different levels of mobility may therefore be particularly relevant to this population.

Yoga incorporates physical movement with breathing, attention regulation, relaxation, and other mind-body practices. Chair-based yoga provides an adaptable form of yoga that can be performed while seated and can be modified for individuals who have difficulty with floor-based exercise, prolonged standing, or conventional exercise programs. Mind-body practices incorporated into yoga may also provide potential benefits related to stress regulation, relaxation, sleep, and psychological well-being.

Despite the growing use of yoga and other mind-body practices among individuals with chronic health conditions, there is limited clinical research specifically examining remotely delivered chair-based mind-body yoga for people with lipedema. Additional research is needed to determine whether this type of intervention is feasible to deliver remotely and whether participation is associated with changes in functional mobility and other patient-reported outcomes relevant to lipedema.

The present study was developed from a prior citizen-science mind-body chair yoga program involving individuals with lipedema and/or lymphedema. That program explored changes in quality-of-life domains including pain, mobility, sleep, and mental health following a six-week gentle chair-based mind-body yoga intervention. The findings provided preliminary information supporting the feasibility of further investigation using a formal clinical research design. The current study is intended to extend that work by using a prospective, randomized, controlled design focused specifically on individuals with lipedema.

The study will evaluate a remotely delivered mind-body chair yoga intervention using a two-arm parallel-group design. Participants will be randomly assigned to either a mind-body chair yoga plus support-group intervention or a support-group-only comparison condition during the primary study period. The comparison condition is intended to provide social support and participant engagement while allowing evaluation of outcomes associated with the addition of the yoga intervention. Participants assigned to the comparison condition will subsequently be offered the opportunity to participate in the chair yoga program following completion of the primary study period.

The intervention is designed to be accessible to participants with varying levels of physical ability. Chair-based movement allows participants to remain seated for much of the practice while adapting movements according to individual needs and abilities. The mind-body component includes practices such as breathing, relaxation, meditation, and gentle movement. The remote format is intended to reduce barriers associated with travel and access to in-person programs and may provide a practical model for individuals who have difficulty attending conventional exercise or yoga classes.

The primary focus of the study is functional mobility. Functional mobility is an important aspect of quality of life for individuals with lipedema because limitations in movement may affect independence, participation in daily activities, physical activity, and overall well-being. The study will also examine additional patient-reported domains relevant to lipedema, including symptom severity, pain, sleep, and mental well-being.

In addition to quantitative measures, the study will collect information about participant experiences with the intervention. These data will help characterize how participants perceive the accessibility, acceptability, and usefulness of the program and may identify factors that influence participation and adherence.

The study is intended as a feasibility and effectiveness investigation and is not designed to establish that chair yoga is a treatment or cure for lipedema. Rather, it will provide preliminary clinical evidence regarding whether a structured, remotely delivered mind-body chair yoga intervention can be implemented with individuals with lipedema and whether participation is associated with changes in functional mobility and related quality-of-life outcomes.

Results from this study may provide information to guide the design of future, larger clinical trials and may contribute to the evidence base concerning accessible movement and mind-body approaches for individuals living with lipedema.

Conditions
Lipedema
Being tested
Mind-Body Chair Yoga + Support Group, Support Group
Keywords
Lipedema, Chair Yoga, Functional Mobility, Mind-Body Yoga, Physical Function, Quality of Life, Mind-Body Intervention, Remote Intervention, Telehealth, Yoga, Exercise
Medical subject headings
Lipedema, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mind-Body Chair Yoga + Support GroupBehavioural

    A remotely delivered, six-week mind-body chair yoga program designed for individuals with lipedema. The intervention incorporates gentle, adaptable chair-based yoga movements, breathing practices, guided meditation, relaxation, and other accessible mind-body practices. Sessions are designed to accommodate participants with varying levels of mobility and physical ability, with movements modified as needed. The program aims to support functional mobility and quality of life. Participants assigned to this intervention will also participate in the study's scheduled support group.

  • Support GroupOther

    A remotely delivered support group for individuals with lipedema. Sessions provide opportunities for participants to share experiences, discuss challenges associated with living with lipedema, exchange coping strategies, and receive peer encouragement in a supportive group environment. The support group is intended to provide social connection and participant engagement throughout the study period. Participants assigned to the support-group-only arm will not receive the mind-body chair yoga intervention during the primary study period. Following completion of the primary study period and outcome assessments, these participants will be offered the opportunity to participate in the mind-body chair yoga program.

Study groups in NCT07917195
Study groupRoleWhat they receive
Mind-Body Chair Yoga + Support GroupExperimentalParticipants assigned to the experimental arm will receive a remotely delivered mind-body chair yoga intervention in addition to participation in the scheduled support group. The chair yoga program will incorporate gentle, adaptable chair-based yoga movements along with breathing practices, relaxation, meditation, and other accessible mind-body practices. The intervention is designed for individuals with varying levels of mobility and can be modified according to individual abilities. Participants will participate in the intervention during the primary study period and will also have access to the support group provided as part of the study.
Receives: Behavioral: Mind-Body Chair Yoga + Support Group
Support Group OnlyActive comparatorParticipants assigned to the active comparator arm will participate in the scheduled remote support group during the primary study period without receiving the mind-body chair yoga intervention. The support group will provide opportunities for participant interaction, discussion, encouragement, and shared experiences related to living with lipedema. Following completion of the primary study period and outcome assessments, participants in this arm will be offered the opportunity to participate in the mind-body chair yoga program.
Receives: Other: Support Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of the Remote Mind-Body Chair Yoga Intervention

    Feasibility will be assessed using recruitment, retention, adherence, intervention completion, and participant acceptability measures.

    Recruitment feasibility: number/percentage enrolled relative to those screened Retention: percentage completing the 7-week intervention Adherence: attendance and/or completion of prescribed sessions Intervention acceptability: participant ratings of satisfaction or acceptability will be measured using the Participant Program Acceptability Questionnaire. Scale is 1-5. 1= Strongly Disagree, 5 = Strongly Agree.

    Study completion: percentage completing baseline and post-intervention assessments Adverse events: number and type of events related to the intervention. This is measured by Post Class Check-In and Weekly Check-In.

    Measured: Baseline to immediately post-intervention (7 weeks) and 3-month follow-up.

Secondary outcomes (3)
  1. Change in Functional Mobility from Baseline to Post-Intervention

    Functional mobility will be assessed at baseline and post-intervention using the: Lower Extremity Functional Scale (LEFS) - Scale is 0-4. 0=Extreme Difficulty or Unable to Perform Activity. 4=No Difficulty Upper Extremity Functional Index (UEFI) - Scale is 0-4. 0=Extreme Difficulty or Unable to Perform Activity. 4=No Difficulty 30 Second Chair Stand Assessment - There is no rating for this. This is rated based on the number of chair-to-standing transitions within 30 seconds.

    The change in functional mobility from baseline to post-intervention will be compared between participants assigned to the mind-body chair yoga plus support group and those assigned to the support-group-only comparison group.

    Measured: Baseline to immediately post-intervention (7 weeks) and 3-month follow-up.

  2. Change in Mental Well-Being from Baseline to Post-Intervention

    Change in mental well-being will be assessed using the Lipedema Psychological Functioning Questionnaire in the study protocol. Scale is: 0-6. 0=Never, 6=Always

    Scores collected at baseline and post-intervention will be compared between the two study groups.

    Measured: Baseline to immediately post-intervention (7 weeks) and 3-month follow-up.

  3. Change in Pain Severity from Baseline to Post-Intervention

    Change in pain severity will be assessed using the Brief Pain Inventory. Scale is: 0 to 10 (depends on the question). Different options for zero can be no pain, no relief, or does not interfere. Ten equals pain as bad you can imagine, complete relief, or completely interferes.

    This is specified in the study protocol. Baseline and post-intervention scores will be compared between the two study groups.

    Measured: Baseline to immediately post-intervention (7 weeks) and 3-month follow-up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Nov 2026
  2. Study startJan 2027 (estimated)
  3. Primary completionMar 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a two-arm, parallel-group, randomized clinical study. Eligible participants will be randomly assigned in a 1:1 ratio to either the mind-body chair yoga plus support group or the support-group-only comparison group. Participants will remain in their assigned group throughout the primary study period. Outcomes will be assessed at baseline and following the intervention period to compare changes in functional mobility and other study measures between groups. After completion of the primary study period, participants assigned to the support-group-only comparison group will be offered the opportunity to participate in the mind-body chair yoga program.
Masking
None (open label)
Enrolment
73 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07917195
Sponsor's protocol ID
MBY-LIP-MOB-2027-01
Acronym
LIP-MOVE
Status last verified
Oct 2026
First submitted
13 Oct 2026
Last updated
4 Nov 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with other researchers because the study involves sensitive health-related information, including information about lipedema symptoms, functional mobility, and mental well-being. To protect participant privacy and confidentiality, individual-level data will be accessible only to authorized study personnel and managed in accordance with the study's approved data security procedures and informed consent. Study findings may be disseminated through publications, presentations, and other scholarly communications using aggregate or summary data that do not identify individual participants.

Publications

  • 13. Stephens, I. (2017). Medical yoga therapy. Children, 4(2), 12.

  • Simarro JL, Michelini S, Andres-Gasco M, Lebrero Garcia A, Ortega Abad D, Margalejo Lombardo J, Buj Vargas J, Sanchez-Costa JT, Martin Martinez MA. Clinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain. Biomedicines. 2025 Dec 11;13(12):3049. doi: 10.3390/biomedicines13123049.

    PubMed 41463059
  • Mortimer PS, Rockson SG. New developments in clinical aspects of lymphatic disease. J Clin Invest. 2014 Mar;124(3):915-21. doi: 10.1172/JCI71608. Epub 2014 Mar 3.

    PubMed 24590276
  • Kunzova M, Lagova E, Keith L. Mental and physical health burden and quality of life in Czech women with lipedema. Front Glob Womens Health. 2025 Jul 24;6:1629077. doi: 10.3389/fgwh.2025.1629077. eCollection 2025.

    PubMed 40778367
  • 9. Kuhn, A. L. (2026). Accessible Mind-Body Movement Therapies for Low Back Pain Management. The Journal for Nurse Practitioners, 22(6), 93-105, https://doi.org/10.1016/j.nurpra.2026.105788.

  • Keith L, Seo C, Wahi MM, Huggins S, Carmody M, Faerber G, Forner-Cordero I, Michelini S, Rapprich S, Rockson SG. Proposed Framework for Research Case Definitions of Lipedema. Lymphat Res Biol. 2024 Apr;22(2):93-105. doi: 10.1089/lrb.2023.0062. Epub 2024 Mar 28.

    PubMed 38546398
  • Herbst KL, Kahn LA, Iker E, Ehrlich C, Wright T, McHutchison L, Schwartz J, Sleigh M, Donahue PM, Lisson KH, Faris T, Miller J, Lontok E, Schwartz MS, Dean SM, Bartholomew JR, Armour P, Correa-Perez M, Pennings N, Wallace EL, Larson E. Standard of care for lipedema in the United States. Phlebology. 2021 Dec;36(10):779-796. doi: 10.1177/02683555211015887. Epub 2021 May 28.

    PubMed 34049453
  • Hakim AJ, Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. 2003 Apr;57(3):163-6.

    PubMed 12723715
  • Ghods M, Georgiou I, Schmidt J, Kruppa P. Disease progression and comorbidities in lipedema patients: A 10-year retrospective analysis. Dermatol Ther. 2020 Nov;33(6):e14534. doi: 10.1111/dth.14534. Epub 2020 Nov 22.

    PubMed 33184945
  • 4. Executive Committee of the International Society of Lymphology. (2020). The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the International Society of Lymphology. Lymphology, 53, 3-19.

  • Dudek JE, Bialaszek W, Ostaszewski P. Quality of life in women with lipoedema: a contextual behavioral approach. Qual Life Res. 2016 Feb;25(2):401-408. doi: 10.1007/s11136-015-1080-x. Epub 2015 Jul 28.

    PubMed 26216585
  • Clarke C, Kirby JN, Smidt T, Best T. Stages of lipoedema: experiences of physical and mental health and health care. Qual Life Res. 2023 Jan;32(1):127-137. doi: 10.1007/s11136-022-03216-w. Epub 2022 Aug 16.

    PubMed 35972618
  • Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. Phys Ther. 1999 Apr;79(4):371-83.

    PubMed 10201543

Questions about this trial

What is this clinical trial studying?

A study testing Mind-Body Chair Yoga + Support Group and Support Group in people with Lipedema, run by Cynthia Beers.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Cynthia L Beers, Principal Investigator, MS 500ERYT (717-571-4610, cindy@cindybeers.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of the Remote Mind-Body Chair Yoga Intervention (time frame: Baseline to immediately post-intervention (7 weeks) and 3-month follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07917195, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in